Bios Clinical Opportunity Fund, LP - 10%+ Owner at Actuate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
ACTU
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Bios Clinical Opportunity Fund, LP since 9/12/2023

Holdings reported by Bios Clinical Opportunity Fund, LP for Actuate Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 84.9K Aug 12, 2024 Directly held by BP Directors, LP
Common Stock 69.4K Aug 12, 2024 Directly held by Circle K Invesco, LP
Common Stock 61K Aug 12, 2024 Direct
Common Stock 8.06K Aug 12, 2024 Directly held by KF Legacy Trust U/A/D December 7, 2016
Common Stock 8.06K Aug 12, 2024 Directly held by MF Legacy Trust U/A/D December 7, 2016

There are no transactions reported by Bios Clinical Opportunity Fund, LP for Actuate Therapeutics, Inc.